Preemptive use of lamivudine reduces hepatitis B exacerbation after allogeneic hematopoietic cell transplantation

Hepatology

Volumn 36, Issue 3, 2002, Pages 702-709

  Lau, George K K ^a   He, Ming Liang ^a   Fong, Daniel Y T ^a   Bartholomeusz, Angeline ^b   Au, Wing Yan ^a   Lie, Albert K W ^a   Locarnini, Stephen ^b   Liang, Raymond ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS B SURFACE ANTIGEN; IMMUNOSUPPRESSIVE AGENT; LAMIVUDINE; VIRUS DNA;

ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL EXAMINATION; DISEASE EXACERBATION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS B; HUMAN; LIVER FAILURE; MALE; MORBIDITY; MORTALITY; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROBABILITY; SURVIVAL; TREATMENT OUTCOME; VIROLOGY;

EID: 0036730423     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.35068     Document Type: Article

References (46)

1. Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: A review of the problem
2. Hepatitis B infection in China
3. Reactivation of chronic hepatitis B virus infection by cancer chemotherapy
4. Acute flares in chronic hepatitis B: The natural and unnatural history of an immunologically mediated liver disease
5. Effect of immunosuppressive and antiviral agents on hepatitis B virus replication in vitro
6. High HBV DNA viral load is the most significant risk factor for hepatitis B reactivation in hepatitis B surface antigen positive patients treated with autologous hematopoietic cell transplantation
7. Changing trends in allogeneic bone marrow transplantation for leukemia in the 1980s
8. Liver disease after bone marrow transplantation: The Taiwan experience
9. Allogeneic marrow transplantation in patients positive for hepatitis B surface antigen
10. Impact of liver disease and hepatitis infections on allogeneic bone marrow transplantation in Europe: A survey from the European Bone Marrow Transplantation (EBMT) Group: Infectious Diseases Working Party
11. Hepatitis B virus infection in allogeneic bone marrow transplantation
12. Hepatitis B reactivation following allogeneic bone marrow transplantation: A case report and review of the literature
13. Reverse seroconversion of hepatitis B after allogeneic bone marrow transplantation: A retrospective study of 37 patients with pretransplant anti-HBs and anti-HBc
14. Hepatitis B associated liver failure following bone marrow transplantation
15. Fulminant hepatitis due to reactivation of chronic hepatitis B virus infection after allogeneic bone marrow transplantation
16. Reactivation of precore mutant hepatitis B virus leading to fulminant hepatic failure following cytotoxic treatment
17. Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA
18. Treatment of HBV reactivation after withdrawal of immunosuppression
19. A one-year trial of lamivudine for chronic hepatitis B
20. Lamivudine as initial treatment for chronic hepatitis B in the United States
21. A double blind, placebo-controlled study to assess the effect of famciclovir on viral replication in patients with chronic hepatitis B virus infection
22. Famciclovir in chronic hepatitis B: Results of a dose-finding study
23. A randomized, placebo-controlled study to evaluate the efficacy of 12-month famciclovir treatment in patients with chronic hepatitis B e antigen-positive hepatitis B
24. Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy
25. Case report: Lamivudine therapy for submassive hepatic necrosis due to reactivation of hepatitis B following chemotherapy
26. Successful treatment with lamivudine for fulminant reactivated hepatitis B infection following intensive therapy for high-grade non-Hodgkin's lymphoma
27. Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infection
28. Efficacy of famciclovir in the treatment of lamivudine resistance related to an atypical hepatitis B virus mutant
29. Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: Precore/core mutations may play an important role
30. Use of famciclovir to prevent HBV reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation
31. Venocclusive disease of the liver after bone marrow transplantation: Diagnosis, incidence, and predisposing factors
32. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors
33. Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region
34. Cross-resistance testing of antihepadnaviral compounds using novel recombinant baculoviruses which encode drug-resistant strains of hepatitis B virus
35. Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy
36. Efficacy of lamivudine to prevent hepatitis reactivation in hepatitis B virus-infected patients treated for non-Hodgkin lymphoma
37. Lamivudine-induced pure red cell aplasia
38. Hepatitis viruses and hematopoietic cell transplantation: A guide to patient and donor management
39. Clearance of HBsAg after bone marrow transplantation: Role of adoptive immunity transfer
40. Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B
41. Acute exacerbation of chronic hepatitis B virus infection after withdrawal of lamivudine therapy
42. Management of hepatitis B: 2000-Summary of a workshop
43. Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy
44. Acute liver graft failure due to emergence of lamivudine resistant hepatitis B virus: Rapid resolution during treatment with adefovir
45. Combination chemotherapy for hepatitis B virus: The final solution?
46. Combination therapy with lamivudine and famciclovir for Chronic hepatitis B infected Chinese: A viral dynamics study